Published in Lancet on April 27, 1968
The distribution and metabolism of arachidonic acid in rabbit platelets during aggregation and its modification by drugs. Br J Pharmacol (1977) 1.87
Structural changes in human serum albumin induced by ingestion of acetylsalicylic acid. J Clin Invest (1969) 1.75
A comparison of an effect of different anti-inflammatory drugs on human platelets. J Clin Pathol (1970) 1.27
Inhibition by aspirin of release of antiheparin activity from human platelets. Br Med J (1969) 1.25
Platelets, fibroblasts, and inflammation: tissue reactions to platelets injected subcutaneously. Am J Pathol (1980) 1.17
Diagnosis of deep vein thrombosis using autologous indium-III-labelled platelets. Br Med J (Clin Res Ed) (1981) 1.12
Effect of diflunisal on platelet function and blood coagulation. Br J Clin Pharmacol (1977) 0.91
Effect of racemic ibuprofen dose on the magnitude and duration of platelet cyclo-oxygenase inhibition: relationship between inhibition of thromboxane production and the plasma unbound concentration of S(+)-ibuprofen. Br J Clin Pharmacol (1991) 0.87
Lowering of kininogen in rat blood by adrenaline and its inhibition by sympatholytic agents, heparin and aspirin. Br J Pharmacol (1974) 0.81
Platelets, acute inflammation and inflammatory mediators. Agents Actions (1976) 0.78
Editorial: Aspirin and what else? Br Med J (1974) 0.75
Letter: Aspirin and what else? Br Med J (1974) 0.75
1-n-Butylimidazole: a potent and selective inhibitor of 'thromboxane synthetase' [proceedings]. Br J Pharmacol (1978) 0.75
Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies. Circulation (1991) 5.66
Effects of salicylates on human platelets. Lancet (1968) 4.59
The quantitation of platelet aggregation induced by four compounds: a study in relation to myocardial infarction. Thromb Diath Haemorrh (1966) 2.50
Treatment of Infective Hepatitis with Methionine. Br Med J (1945) 1.79
Platelet function studies before and after operation and the effect of postoperative thrombosis. J Lab Clin Med (1974) 1.74
Platelet function in venous thrombosis and low-dosage heparin. Lancet (1972) 1.53
Temperature and risk factors for ischaemic heart disease in the Caerphilly prospective study. Br Heart J (1993) 1.52
Refractory state of platelet aggregation with major operations. Lancet (1971) 1.48
The endothelial von Willebrand factor in venous occlusion blood. Thromb Haemost (1997) 1.43
"Rebleeding" the reversal of shear stress activation of platelets--a possible clue to thrombogenesis. Thromb Res (1992) 1.41
Puerperal thromboembolism and aspirin ingestion. Lancet (1970) 1.38
Some long term effects of smoking on the haemostatic system: a report from the Caerphilly and Speedwell Collaborative Surveys. J Clin Pathol (1987) 1.31
Haemostatic factors associated with ischaemic heart disease in men aged 45 to 64 years. The Speedwell study. Br Heart J (1982) 1.31
A comparison of an effect of different anti-inflammatory drugs on human platelets. J Clin Pathol (1970) 1.27
Platelet-bound and soluble platelet factor 4: effects of aggregating agents, of aggregation, and of aspirin. Proc Soc Exp Biol Med (1970) 1.16
Letter: Heparin thrombin clotting-time and platelet factor 4. Lancet (1974) 1.15
Blood changes in atherosclerosis and long after myocardial infarction and venous thrombosis. Thromb Diath Haemorrh (1975) 1.15
Two in-vivo studies comparing high and low aspirin dosage. Lancet (1971) 1.10
Letter: Platelet counts in normal pregnancy. J Clin Pathol (1976) 1.08
Vitamin B12 in the rat kidney. Evidence for an association with lysosomes. Arch Biochem Biophys (1970) 1.08
Gender and employment grade differences in blood cholesterol, apolipoproteins and haemostatic factors in the Whitehall II study. Atherosclerosis (1993) 1.07
Ischemic heart disease and platelet aggregation. The Caerphilly Collaborative Heart Disease Study. Circulation (1991) 1.05
Exercise, fibrinogen, and other risk factors for ischaemic heart disease. Caerphilly Prospective Heart Disease Study. Br Heart J (1993) 1.04
Anti-thormbin III and heparin clotting times in thrombosis and atherosclerosis. Thromb Diath Haemorrh (1974) 1.01
Acute platelet changes after large meals of saturated and unsaturated fats. Lancet (1976) 1.01
Superconductivity in heavy alkaline-Earth intercalated graphites. Phys Rev Lett (2007) 1.00
Effect of aggregating agents and their inhibitors on the mean platelet shape. J Clin Pathol (1966) 0.98
Effect of a diet of polyunsaturated fats on some platelet-function tests. Lancet (1976) 0.98
Heparin neutralizing activity test in the diagnosis of acute myocardial infarction. J Clin Pathol (1975) 0.98
Dietary depletion of vitamin B12 and the excretion of methylmalonic acid in the rat. Br J Nutr (1969) 0.98
Platelet tests in the prediction of myocardial infarction and ischaemic stroke: evidence from the Caerphilly Prospective Study. Br J Haematol (2001) 0.96
Platelet functions in relation to diet and serum lipids in British farmers. Br Heart J (1981) 0.94
Effects of adenosine diphosphate and adrenaline on mean platelet shape. Nature (1965) 0.93
A nine-year survey of Fallopian tube dysfunction in human infertility. Diagnosis and therapy. Fertil Steril (1970) 0.91
Stressed template bleeding-time and other platelet-function tests in myocardial infarction. Lancet (1973) 0.89
Some interactions between human platelets and glass: von Willebrand's disease compared with normal. J Clin Pathol (1967) 0.89
A comparison of platelet stickiness tests during an atromid-S trial. Thromb Diath Haemorrh (1966) 0.89
Haemostatic factors and ischaemic heart disease. The Caerphilly study. Br Heart J (1985) 0.89
"Exhausted" platelets continue to circulate. Lancet (1978) 0.88
Bleeding time, stroke and myocardial infarction: the Caerphilly prospective study. Platelets (2003) 0.88
Platelet stickiness. Annu Rev Med (1966) 0.87
Cell membrane damage, platelet stickiness and some effects of aspirin. Br J Haematol (1969) 0.87
Effects of a fish oil supplement on serum lipids, blood pressure, bleeding time, haemostatic and rheological variables. A double blind randomised controlled trial in healthy volunteers. Atherosclerosis (1987) 0.87
The Haldane Haemoglobinometer. Br Med J (1944) 0.86
A Clinical Evaluation of Some Tests of Liver Function. Br Med J (1944) 0.85
Platelet function in acute myocardial infarction patients compared with controls. Thromb Haemost (1980) 0.85
The association of platelet and red cell count with platelet impedance changes in whole blood and light-scattering changes in platelet rich plasma: evidence from the Caerphilly Collaborative Heart Disease Study. Thromb Haemost (1990) 0.85
The mechanisms of venous thrombosis. Anticoagulants, aspirin, and heparin. Mod Concepts Cardiovasc Dis (1973) 0.84
Coronary heart disease, fibrinogen, and plasma heparin neutralising activity. Lancet (1981) 0.84
Platelet function long after arterial and venous thrombosis. Thromb Diath Haemorrh (1974) 0.84
Comparison of the effect of heparin and citrate on platelet aggregation. J Clin Pathol (1969) 0.84
Platelet function: a guide to platelet membrane structure. Ser Haematol (1970) 0.83
Platelets in the prediction of thrombotic risk. Atherosclerosis (1982) 0.82
Fibrinogen catabolism in the surgically treated patient and in those with postoperative venous thrombosis. Correlation of plasma fibrinogen chromatographic findings with 125I-labeled fibrinogen scan findings. J Lab Clin Med (1977) 0.81
Intra-platelet platelet factor 4 (IP.PF4) and the heparin-mobilisable pool of PF4 in health and atherosclerosis. Thromb Haemost (1984) 0.80
Rate of fibrinogen turnover in thrombosis. Lancet (1972) 0.80
Heparin, platelets, and venous thrombosis. Am Heart J (1973) 0.80
Effect of salicylates on human platelets. Lancet (1968) 0.80
How does low-dose heparin prevent thrombosis? Lancet (1980) 0.80
Platelets, aspirin, and cardiovascular disease. Postgrad Med J (1998) 0.80
High shearing forces in blood: haemostasis, thrombosis and atherogenesis. Thromb Res (1994) 0.80
Platelet responses to cardiopulmonary bypass. Assessment by a shear stress activation technique. J Cardiovasc Surg (Torino) (1992) 0.79
Heart valve stenosis and von Willebrand's factor multimers. Lancet (1992) 0.79
Unconventional T-H phase diagram in the noncentrosymmetric compound Yb2Fe12P7. Phys Rev Lett (2010) 0.79
Inter-relationships between haemostatic tests and the effects of some dietary determinants in the Caerphilly cohort of older men. Blood Coagul Fibrinolysis (1993) 0.79
Platelet adhesion and aggregation. Br Med J (1972) 0.78
Platelets and the vessel wall: how much aspirin? Lancet (1980) 0.78
Intraplatelet serotonin and plasma 5-hydroxyindoles in health and disease. Blood (1981) 0.78
Ticlopidine - an antiplatelet drug: effects in human volunteers. Thromb Res (1978) 0.78
Platelet and other tests followed sequentially for 14 days after operation. Clin Lab Haematol (1984) 0.78
Blood group, von Willebrand's factor and heart disease. Thromb Res (1990) 0.78
The platelets in glandular fever and idiopathic thrombocytopenic purpura. Br J Haematol (1978) 0.77
Letter: A relationship between platelet volume and platelet number. Thromb Diath Haemorrh (1974) 0.77
A comparison between the plasma concentration of immunologically assayed platelet factor 4 and beta-thromboglobulin and the heparin thrombin clotting time. Thromb Res (1979) 0.77
Platelet aggregation and incident ischaemic heart disease in the Caerphilly cohort. Heart (1998) 0.76
Heparin and platelets. Curr Ther Res Clin Exp (1975) 0.76
Vaginitis: its diagnosis and treatment. Can Fam Physician (1970) 0.75
New directions in anticoagulant and antiplatelet treatment. Heart (1996) 0.75
Changes in the heparin neutralising activity of platelet poor plasma after immunisation. J Clin Pathol (1979) 0.75
Susceptibility to aspirin bleeding. Br Med J (1970) 0.75
Letter: Adjustment to low-dose heparin to prevent thrombosis. Br Med J (1975) 0.75
Causes of birth asphyxia and trauma. Can Med Assoc J (1966) 0.75
Letter: Intermittent calf compression in prevention of deep venous thrombosis. Br Med J (1974) 0.75
The use of pool cryoglobulin factor 8 concentrate in the management of haemophilia. Proc R Soc Med (1967) 0.75
Some effects of mucopolysaccharide stains on platelet aggregation. J Clin Pathol (1970) 0.75
Heat treatment in von Willebrand's disease. Br Med J (Clin Res Ed) (1985) 0.75
Robert Gwyn Macfarlane, 26 June, 1907-26 March, 1987. Thromb Res (1988) 0.75
Superconductivity in the Einstein solid VAl(10.1). J Phys Condens Matter (2012) 0.75
Desmopressin and sheared platelets: a test. Lancet (1988) 0.75
The heparin-mobilisable pool of platelet factor 4: a comparison of intravenous and subcutaneous heparin and Kabi heparin fragment 2165. Thromb Haemost (1985) 0.75
The heparin-mobilizable pool of platelet factor 4 and thrombogenesis. Thromb Haemost (1985) 0.75
Cryoaggregation of platelets in heparinized blood. Thromb Haemost (1982) 0.75
Detection of thrombosis with iodine-125 fibrinogen. Data reassessed. Lancet (1970) 0.75
A pilot study of the effect of Gemfibrozil on some haematological parameters. Thromb Res (1982) 0.75
How much aspirin? Thromb Haemost (1990) 0.75
Cryoaggregation in von Willebrand's disease and other patient groups and the mechanism involved. Thromb Haemost (1985) 0.75
Multiple therapy for multifactorial thrombosis. Thromb Haemost (1987) 0.75
Organizing QA and UR activities under a DRG-based system. QRB Qual Rev Bull (1983) 0.75
Multiple therapy for thrombosis, a multifactorial process. Lancet (1983) 0.75
Chloroquine and platelets. Lancet (1987) 0.75